What is INCY's current stock price?

As of now, INCY is trading at $97.06, with a daily change of +0.13%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

INCY Stock Analysis & IQ Rating | Incyte Corp.

INCY

Incyte Corp.

$97.06

+$0.36 | +0.13%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$109.28

MKT CAP

$19.01B

52W Low

$53.56

VOL

$486.01K

P/E Ratio

16.37

AVG VOL

$2.62M

RSI

41.93

TREND

Sideways

INCY Stock IQ

Login to see Incyte Corp. (INCY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

INCY Target Price

Login to display

Strengths

INCY Rewards

Earnings are forecast to grow

INCY Rewards

Upgraded on attractively valued

INCY Rewards

Trading below its fair value

INCY Price Performance

$105.98 (-8.42%)

$83.1 (+16.80%)

$68.94 (+40.79%)

$67.06 (+44.74%)

1year

6month

3month

1month

INCY Risk Level

INCY has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

INCY Analysts Opinion

INCY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

INCY Analysts Opinion

INCY Analysts opinion is positive and it remained unchanged from the past 3 months

INCY Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

72%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

25%

100%

INCY Street Sentiment

INCY Street Sentiment is extremely bullish and have positive views on the near-term outlook

INCY Performance Sentiment

Sentiments overview associated with INCY events and the stock performance.

72%

17%

Positive

Negative

13 out of 18
events present

3 out of 18
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$101.50

Resistance
Price

$101.32

Current Price Range

$108.26

Show methods +

INCY Latest Analysis +

Wells Fargo Maintains Incyte (INCY) Overweight Recommendation. Fintel reports that on December 8 2025 Wells Fargo maintained coverage of Incyte (NasdaqGS:INCY) with a Overweight recommendation. Analyst Price Forecast Suggests 6.11% Downside

Today

$97.06 | +0.13%

Momentum

Rating

Morgan Stanley Maintains Incyte (INCY) Equal-Weight Recommendation. Fintel reports that on December 8 2025 Morgan Stanley maintained coverage of Incyte (NasdaqGS:INCY) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 6.11% Downside

Today

$97.06 | +0.13%

Potential

Rating

Mizuho Upgrades Incyte (INCY). Fintel reports that on December 8 2025 Mizuho upgraded their outlook for Incyte (NasdaqGS:INCY) from Neutral to Outperform. Analyst Price Forecast Suggests 6.11% Downside

Today

$97.06 | +0.13%

Momentum

Potential

Rating

Incytes New Therapy Shows Signs Of Disease-Modifying Potential In Rare Blood Cancer. ) on Sunday revealed new clinical data from two Phase 1 studies of INCA033989 for mutCALR-expressing at the 2025 American Society of Hematology (ASH) Annual Meeting.The preliminary analysis (data cut off September 25 2025) evaluated the safety and efficacy of INCA033989 in myelofibrosis (MF) patients with as measured by spleen volume reduction ≥25% (SVR25) and ≥35% (SVR35) change in MPN-Symptom Assessment Form

Mon Dec 8, 2025

$96.70 | -5.68%

Activity

Potential

Incyte Corporation (INCY) Presents at Evercore 8th Annual Healthcare Conference Transcript.

Wed Dec 3, 2025

$101.50 | +0.06%

Activity

Incyte Corporation (INCY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.

Tue Dec 2, 2025

$101.44 | -0.59%

Activity

Barclays Maintains Incyte (INCY) Overweight Recommendation. Fintel reports that on November 24 2025 Barclays maintained coverage of Incyte (NasdaqGS:INCY) with a Overweight recommendation. Analyst Price Forecast Suggests 7.38% Downside

Tue Nov 25, 2025

$105.54 | -0.65%

Momentum

Rating

Commit To Purchase Incyte At $87.50 Earn 12.3% Annualized Using Options. Investors considering a purchase of Incyte Corporation (Symbol: INCY) shares but tentative about paying the going market price of $102.23/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in part

Fri Nov 21, 2025

$102.06 | +0.21%

Activity

Potential

Why Incyte (INCY) is a Top Momentum Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Thu Nov 20, 2025

$101.76 | +0.43%

Momentum

Why Incyte (INCY) is a Top Value Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Nov 19, 2025

$101.32 | -2.47%

Potential

FAQ About INCY Stock Insights

What is INCY current stock price?

What are INCY stock strengths?

What is INCY Risk Level?

What is INCY market cap and volume?

What is INCY current Stock IQ?

Should I buy INCY stock right now?

Is INCY a Strong Buy right now?

What does a 'Strong Buy' rating mean for INCY?

What does a 'Strong Sell' rating mean for INCY?

What factors influence INCY's Stock IQ?

Explore our INCY Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored INCY Stock Strategies
Effective Risk Management

FIND US ON

Receive our INCY Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

INCY

Incyte Corp.

Current Price

$97.06

+$0.36 | +0.13%

52W High

$109.28

MKT CAP

$19.01B

52W Low

$53.56

VOL

$486.01K

P/E Ratio

16.37

AVG VOL

$2.62M

RSI

41.93

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

INCY Rewards

Earnings are forecast to grow

INCY Rewards

Upgraded on attractively valued

INCY Rewards

Trading below its fair value

INCY Price Performance

$105.98 (-8.42%)

$83.1 (+16.80%)

$68.94 (+40.79%)

$67.06 (+44.74%)

1year

6month

3month

1month

INCY Analysts Opinion

INCY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

INCY Analysts Opinion

INCY Analysts opinion is positive and it remained unchanged from the past 3 months

INCY Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

72%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

25%

100%

INCY Street Sentiment

INCY Street Sentiment is extremely bullish and have positive views on the near-term outlook

INCY Risk Level

INCY has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

INCY Performance Sentiment

Sentiments overview associated with INCY events and the stock performance.

72%

17%

Positive

Negative

13 out of 18
events present

3 out of 18
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$101.50

Resistance
Price

$101.32

Current Price Range

$108.26

Show methods +

INCY Stock IQ

Login to unlock Incyte Corp. (INCY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

INCY Latest Analysis

Wells Fargo Maintains Incyte (INCY) Overweight Recommendation. Fintel reports that on December 8 2025 Wells Fargo maintained coverage of Incyte (NasdaqGS:INCY) with a Overweight recommendation. Analyst Price Forecast Suggests 6.11% Downside

Today

$97.06 | +0.13%

Momentum

Rating

Morgan Stanley Maintains Incyte (INCY) Equal-Weight Recommendation. Fintel reports that on December 8 2025 Morgan Stanley maintained coverage of Incyte (NasdaqGS:INCY) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 6.11% Downside

Today

$97.06 | +0.13%

Potential

Rating

Mizuho Upgrades Incyte (INCY). Fintel reports that on December 8 2025 Mizuho upgraded their outlook for Incyte (NasdaqGS:INCY) from Neutral to Outperform. Analyst Price Forecast Suggests 6.11% Downside

Today

$97.06 | +0.13%

Momentum

Potential

Rating

Incytes New Therapy Shows Signs Of Disease-Modifying Potential In Rare Blood Cancer. ) on Sunday revealed new clinical data from two Phase 1 studies of INCA033989 for mutCALR-expressing at the 2025 American Society of Hematology (ASH) Annual Meeting.The preliminary analysis (data cut off September 25 2025) evaluated the safety and efficacy of INCA033989 in myelofibrosis (MF) patients with as measured by spleen volume reduction ≥25% (SVR25) and ≥35% (SVR35) change in MPN-Symptom Assessment Form

Mon Dec 8, 2025

$96.70 | -5.68%

Activity

Potential

Incyte Corporation (INCY) Presents at Evercore 8th Annual Healthcare Conference Transcript.

Wed Dec 3, 2025

$101.50 | +0.06%

Activity

Incyte Corporation (INCY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.

Tue Dec 2, 2025

$101.44 | -0.59%

Activity

Barclays Maintains Incyte (INCY) Overweight Recommendation. Fintel reports that on November 24 2025 Barclays maintained coverage of Incyte (NasdaqGS:INCY) with a Overweight recommendation. Analyst Price Forecast Suggests 7.38% Downside

Tue Nov 25, 2025

$105.54 | -0.65%

Momentum

Rating

Commit To Purchase Incyte At $87.50 Earn 12.3% Annualized Using Options. Investors considering a purchase of Incyte Corporation (Symbol: INCY) shares but tentative about paying the going market price of $102.23/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in part

Fri Nov 21, 2025

$102.06 | +0.21%

Activity

Potential

Why Incyte (INCY) is a Top Momentum Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Thu Nov 20, 2025

$101.76 | +0.43%

Momentum

Why Incyte (INCY) is a Top Value Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Nov 19, 2025

$101.32 | -2.47%

Potential

Discover INCY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of INCY. We're here to help you make informed investment decisions today.

FIND US ON

Receive our INCY Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

INCY Stock trends

INCY Stock performance

INCY Stock analysis

INCY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INCY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INCY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

INCY Stock Analysis & IQ Rating | Incyte Corp.

INCY Stock IQ

INCY Target Price

INCY Risk Level

INCY Analysts Opinion

INCY Street Sentiment

INCY Performance Sentiment

Technical Price Levels

Explore our INCY Stock insights

Receive our INCY Daily Alerts

INCY Street Sentiment

INCY Risk Level

Technical Price Levels

Discover INCY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of INCY. We're here to help you make informed investment decisions today.

Receive our INCY Daily Alerts

INCY Runner Alarm